Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 185 clinical trials
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

This randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with triple-negative breast cancer. Drugs used in chemotherapy, such as doxorubicin hydrochloride, cyclophosphamide, paclitaxel, and carboplatin, work in different ways to stop the growth of tumor cells, …

paclitaxel
primary tumor
adenocarcinoma
breast conserving surgery
biomarker analysis
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 814 views
  • 24 Jan, 2021
  • +810 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

metastatic cancer
corticosteroids
luteinizing hormone
brain metastases
oophorectomy
Northwest Hospital Center
 (3.8 away) Contact site
  • 6087 views
  • 20 Jun, 2021
  • +1016 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

acalabrutinib
ibrutinib
stem cell transplantation
b-cell lymphoma
large b-cell lymphoma
TG Therapeutics Investigational Trial Site
 (7.6 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +201 other locations
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma

This randomized phase III trial studies how well combination chemotherapy (vincristine sulfate, dactinomycin, cyclophosphamide alternated with vincristine sulfate and irinotecan hydrochloride or vinorelbine) works compared to combination chemotherapy plus temsirolimus in treating patients with rhabdomyosarcoma (cancer that forms in the soft tissues, such as muscle), and has an intermediate chance …

alveolar rhabdomyosarcoma
actinomycin
platelet count
vincristine
vinorelbine
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 292 views
  • 20 Jun, 2021
  • +290 other locations
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

PEPPER is a randomized study comparing the three most commonly used anticoagulants in North America in patients who have elected to undergo primary or revision hip or knee joint replacement surgery. The anticoagulants being compared are enteric coated aspirin, low intensity warfarin, and rivaroxaban.

rivaroxaban
warfarin
anticoagulants
total knee replacement
embolism
Sinai Hospital
 (7.7 away) Contact site
  • 324 views
  • 26 Jan, 2021
  • +34 other locations
Platinum Based Chemotherapy or Capecitabine in Treating Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

This randomized phase III trial studies how well cisplatin or carboplatin (platinum based chemotherapy) works compared to capecitabine in treating patients with remaining (residual) basal-like triple-negative breast cancer following chemotherapy after surgery (neoadjuvant). Drugs used in chemotherapy, such as cisplatin, carboplatin and capecitabine, work in different ways to stop the …

warfarin
international normalized ratio
primary tumor
weak
anthracyclines
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 508 views
  • 24 Jan, 2021
  • +702 other locations
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

This randomized phase III trial studies how well pembrolizumab works in treating patients with triple-negative breast cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

corticosteroids
mk-3475
oophorectomy
endocrine therapy
hepatitis
University of Maryland Saint Joseph Medical Center
 (7.6 away) Contact site
  • 1080 views
  • 20 Jun, 2021
  • +649 other locations
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

This phase III trial studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by …

cytopenia
myeloid leukemia
cytarabine
leukemia
cancer
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 153 views
  • 31 May, 2021
  • +141 other locations
Zoster Eye Disease Study

This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.

rash
vaccination
shingrix
zoster vaccine
valacyclovir
Crossroads Eye Physician
 (0.5 away) Contact site
  • 591 views
  • 06 May, 2021
  • +84 other locations
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Measuring biomarkers in tumor cells may help plan when effective treatment …

carboplatin
catecholamines
tumor cells
cancer
mycn protein
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 265 views
  • 03 Jun, 2021
  • +121 other locations